KRYS R&D Expense Growth

Krystal Biotech Inc · R&D Expense Growth

KRYS logo

KRYS R&D Expense Growth

Latest reported8.35%
KRYS FY R&D Growth (YoY) (0.00% → 8.35%)
High-resolution chart · PNG

KRYS r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Krystal Biotech Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
8.3475%
15.382%
9.3498%
52.2773%
55.4639%
14.8566%
101.2112%
141.9264%
332.9285%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.